- Investing Ideas
- /
- Global Bank Account Beaters
Global Bank Account Beaters
UPDATED Apr 23, 2024
Companies that are expected to sustainably pay a dividend that beats your savings account (over 3%).
440 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
XOM | US$121.03 | 2.0% | 4.8% | US$479.1b | US$129.81 | PE13.3x | E-0.6% | 3.1% | Energy | ||
JNJ | US$149.56 | 3.3% | -8.0% | US$360.4b | US$173.60 | PE18.8x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
CVX | US$162.85 | 4.1% | -1.9% | US$300.8b | US$181.37 | PE14.1x | E2.3% | 4.0% | Energy | ||
NESN | CHF94.26 | 1.0% | -18.1% | CHF247.1b | CHF108.89 | PE22x | E7.0% | 3.2% | Food, Beverage & Tobacco | ||
KO | US$60.64 | 3.6% | -4.6% | US$261.4b | US$66.14 | PE24.4x | E7.9% | 3.2% | Food, Beverage & Tobacco | ||
1288 | HK$3.54 | 4.4% | 18.0% | HK$1.7t | HK$3.75 | PB0.4x | E4.6% | 7.1% | Banks | ||
ROG | CHF229.70 | 4.4% | -16.4% | CHF185.3b | CHF281.06 | PE15.9x | E8.2% | 4.2% | Pharmaceuticals & Biotech | ||
NOVN | CHF88.94 | 4.8% | -3.0% | CHF181.5b | CHF98.52 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
941 | HK$70.45 | 2.3% | 4.8% | HK$1.5t | HK$84.71 | PE10.5x | E5.2% | 6.8% | Telecom | ||
CSCO | US$48.32 | 1.1% | 3.8% | US$195.7b | US$53.33 | PE14.6x | E0.6% | 3.3% | Tech | ||
3988 | HK$3.46 | 5.5% | 10.5% | HK$1.3t | HK$3.67 | PB0.4x | E-0.7% | 7.4% | Banks | ||
VZ | US$39.70 | -0.2% | 7.5% | US$167.1b | US$45.29 | PE14.8x | E11.8% | 6.7% | Telecom | ||
IBM | US$182.19 | -0.5% | 44.8% | US$167.0b | US$185.93 | PE22.2x | E5.7% | 3.6% | Software | ||
CMCSA | US$40.36 | 3.5% | 10.5% | US$160.3b | US$50.18 | PE10.4x | E2.9% | 3.1% | Media | ||
PM | US$97.66 | 7.8% | -0.5% | US$151.8b | US$108.53 | PE19.1x | E10.4% | 5.3% | Food, Beverage & Tobacco | ||
AMGN | US$273.54 | 3.6% | 14.5% | US$146.7b | US$300.27 | PE21.8x | E8.9% | 3.3% | Pharmaceuticals & Biotech | ||
RY | CA$136.41 | 2.3% | 3.2% | CA$192.9b | CA$144.00 | PB1.8x | E2.4% | 4.0% | Banks | ||
ULVR | UK£38.61 | 3.3% | -11.7% | UK£96.6b | UK£42.22 | PE17.3x | E4.3% | 3.8% | Household | ||
C | US$62.67 | 7.7% | 33.7% | US$119.5b | US$66.97 | PB0.6x | E23.7% | 3.4% | Banks | ||
SAN | €88.85 | 3.1% | -13.3% | €110.9b | €107.76 | PE20.5x | E13.6% | 4.2% | Pharmaceuticals & Biotech | ||
600036 | CN¥33.46 | 0.5% | -1.1% | CN¥830.5b | CN¥38.45 | PB0.8x | E6.7% | 5.9% | Banks | ||
RIO | UK£53.17 | -1.3% | 5.6% | UK£91.5b | UK£60.64 | PE10.7x | E2.3% | 6.4% | Materials | ||
ALV | €270.50 | 3.5% | 21.2% | €105.4b | €277.04 | PE12.5x | E7.5% | 5.1% | Insurance | ||
MDT | US$81.29 | 2.8% | -9.6% | US$107.9b | US$94.75 | PE25.7x | E10.3% | 3.4% | Healthcare |